TR200202078T2 - Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları - Google Patents

Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları

Info

Publication number
TR200202078T2
TR200202078T2 TR2002/02078T TR200202078T TR200202078T2 TR 200202078 T2 TR200202078 T2 TR 200202078T2 TR 2002/02078 T TR2002/02078 T TR 2002/02078T TR 200202078 T TR200202078 T TR 200202078T TR 200202078 T2 TR200202078 T2 TR 200202078T2
Authority
TR
Turkey
Prior art keywords
lipoglycan
compounds
methods
parasitic infections
treat parasitic
Prior art date
Application number
TR2002/02078T
Other languages
English (en)
Inventor
H. Semprevivo Lloyd
Original Assignee
University Of Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Massachusetts filed Critical University Of Massachusetts
Publication of TR200202078T2 publication Critical patent/TR200202078T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bir omurgalida bir ökaryot parazite karsi koruyucu bir bagisiklik tepkisi ortaya çikarmak için bir bilesim ve bunun bir metotu ortaya konmaktadir.Metot bir ökaryotun yüzeyinde bulunan bir lipoglikandan elde edilen bir oligosakarite eslenmis bir tasiyici grup içeren bir bilesimi omurgaliya uygulamayi içermektedir.Bilesim parazite karsi koruyucu bir bagisiklik tepkisi ortaya çikartmaya yetecek bir miktarda uygulanmaktadir.
TR2002/02078T 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları TR200202078T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
TR200202078T2 true TR200202078T2 (tr) 2002-11-21

Family

ID=22411778

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2001/03231T TR200103231T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì
TR2002/02078T TR200202078T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları
TR2002/02066T TR200202066T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2001/03231T TR200103231T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2002/02066T TR200202066T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları

Country Status (17)

Country Link
US (3) US6428793B1 (tr)
EP (1) EP1175226B1 (tr)
JP (1) JP2002538220A (tr)
AT (1) ATE439857T1 (tr)
AU (1) AU771373B2 (tr)
BR (1) BR0008949A (tr)
CA (1) CA2364507A1 (tr)
DE (1) DE60042776D1 (tr)
HU (1) HUP0200466A3 (tr)
MA (1) MA25347A1 (tr)
MX (1) MXPA01009206A (tr)
NO (1) NO20014411L (tr)
NZ (1) NZ514112A (tr)
PL (1) PL203789B1 (tr)
TR (3) TR200103231T2 (tr)
WO (1) WO2000053220A1 (tr)
ZA (1) ZA200107502B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
WO2011047794A2 (en) 2009-10-21 2011-04-28 Eth Zurich Medical utility of glycan-binding proteins and glycans

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5212298A (en) * 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5280113A (en) 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
AU5928999A (en) * 1998-09-21 2000-04-10 Richard D. Cummings Assays for helminth infections

Also Published As

Publication number Publication date
EP1175226A4 (en) 2005-01-05
US7204983B2 (en) 2007-04-17
US7063848B2 (en) 2006-06-20
WO2000053220A1 (en) 2000-09-14
NZ514112A (en) 2003-08-29
TR200103231T2 (tr) 2002-03-21
HUP0200466A3 (en) 2006-11-28
CA2364507A1 (en) 2000-09-14
NO20014411D0 (no) 2001-09-11
PL350989A1 (en) 2003-02-24
US20020160021A1 (en) 2002-10-31
AU771373B2 (en) 2004-03-18
US20060228382A1 (en) 2006-10-12
NO20014411L (no) 2001-11-09
HUP0200466A2 (en) 2002-06-29
US6428793B1 (en) 2002-08-06
DE60042776D1 (de) 2009-10-01
BR0008949A (pt) 2002-09-24
JP2002538220A (ja) 2002-11-12
AU3625100A (en) 2000-09-28
ZA200107502B (en) 2003-02-26
EP1175226B1 (en) 2009-08-19
MA25347A1 (fr) 2001-12-31
EP1175226A1 (en) 2002-01-30
ATE439857T1 (de) 2009-09-15
PL203789B1 (pl) 2009-11-30
TR200202066T2 (tr) 2004-12-21
MXPA01009206A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE60222264D1 (en) Phenylpyrazolderivate als seh-inhibitoren
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE69524403D1 (de) Kohärenter detektor einer aufwärtsverbindung im direktsequenz-cdma-verfahren
YU81991A (sh) Sinergističke terapeutske kompozicije i postupci
ATE453707T1 (de) Verfahren zur isolierung von mesenchymalen stammzellen des haarfollikels
DK0889886T3 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
TR200202078T2 (tr) Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları
MXPA01003501A (es) Metodo para moderar el estres o tension de las plantas.
ES2188788T3 (es) Bi-heteroarilmetoxifenilalquil carboxilatos simetricos que inhiben la biosintesis de leucotrieno.
DE69714011D1 (de) Die erzeugung einer immunantwort gegen erwünschte determinanten
DK1272177T3 (da) Fremgangsmåde og formulering til behandling af resistens over for antihypertensiva og forbundne tilstande
ZA200005413B (en) Cholesterol sulfate compositions for enhancement of stratum corneum function.
TR200000419T2 (tr) Feksofenadin ve türevlerinin biyo elde edilebilirliklerinin arttırılması yöntemi.
ECSP034634A (es) Inhibidores de la farnesil transferasa
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan
AU2001248491A1 (en) Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials
MXPA02011514A (es) El uso de extractos de plantas en una composicion cosmetica para proteger fibras queratinosas.
NO20035038D0 (no) Forhindring av avhengighet ved smertebehandling
ATE243018T1 (de) Transparente körperpflegemittel
WO2001088530A3 (de) Verfahren zum selektieren von inhibitoren für enzyme
ATE361757T1 (de) Stabile fumagillin-formulierung
DE602004020910D1 (de) Haarwuchshemmung
EP1009421A4 (en) PROCESS AND COMPOSITIONS FOR IMPROVED Wounds Healing
DK0776198T3 (da) Transdermalt, terapeutisk system med beskyttelse mod hydrolyse